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The mesothelial lining of the peritoneal cavity represents a
permeability and host defense barrier against local infection [1, 2].
During peritoneal dialysis the mesothelial monolayer is exposed
to high concentrations of glucose, repeated changes in pH and
osmolality and to inadvertently inoculated microorganisms that
may cause inflammation and peritonitis [3]. Inflammatory changes
can eventually result in ultrafiltration failure limiting the efficacy
of peritoneal dialysis [31 The study of interactions between the
peritoneal dialysates, mesothelial cells (MsC) and inflammatory
cells requires stable and differentiated MsC in culture. Permanent
peritoneal mesothelial cells are not widely available and primary
MsC cultures must be used for in vitro studies. The slow growth of
primary MsC, their special culture requirements and the need to
prepare new primary MsC after four to six passages due to
dedifferentiation, limits their usefulness [4, 5]. We, therefore,
established a permanent peritoneal MsC line through transfection
with SV4O T antigen [6—8]. Using a multitude of cell markers and
characteristics we show that this human MsC line maintains
characteristics of primary MsC and can now serve as a reproduc-
ible model of human MsC.
Methods
MsC were obtained from a consenting surgical patient who
underwent elective laparotomy for a reason other than malig-
nancy, and were prepared as described elsewhere [4]. Culture
medium for primary cells was Dulbecco's modified eagle medium
(DMEM; Biochrom KG, Berlin, Germany) supplemented with
10% fetal calf serum (BioWhitaker, Walkersville, USA), 10%
human serum (Sigma, Deisenhofen, Germany), penicillin 100
U/ml/streptomycin 100 jig/mI (Biochrom KG), endothelial cell
growth factor (Boehringer Mannheim, Mannheim, Germany) 5
jig/ml, and heparin 5 U/mI (Braun, Germany). For selection of
stably transfected cells G418 (Sigma) was used. Transfected cells
were cultured in DMEM with 2.5% or 10% bovine serum (Serum
supreme; BioWhittaker) and penicillin/streptomycin 100 U/100
jig/liter and with additional glucose (final concentration 2000
mg/liter; Braun). Cells were incubated at 37°C in a humidified
atmosphere of 5% CO2.
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For primary MsC culture the dishes (Greiner Labortechnik,
Frickenhausen, Germany) and flasks (Primaria, Falcon) had to be
coated with a fibronectin stock solution (50 jig/mI; Boehringer
Mannheim) diluted in PBS using 1.65 jig/cm2, to allow adherent
growth of the cells. The transfected MsC line can be grown in
regular dishes without pretreatment. Medium was changed twice
weekly. Confluent cells were split 1:10 or 1:20 (passages ito 4)
To immortalize primary MsC the plasmids pUC Inwt and
pRc/CMV were used [71. pUC Inwt was a gift from E. Fanning
(Munich, Germany). It contains SV4O sequences in pUCI2 with a
deletion in the late region extending from the Barn HI site
(pos.2533) to the PstI site (pos.l988). A I bp insertion at the SV4O
origin causes a defect in replication. The pRc/CMV confers
resistance to the antibiotics neomycin and geneticin (G4i8). For
transfection io cells were suspended in 400 jig of PBS with the
addition of 10 jig of pUC Inwt and 2 jig of pRc/CMV (both
linearized through digestion with EcoRI) and electroporated
(GenePulser; Bio Rad) using 960 mcF and 230V. Cells were
allowed to recover for three days, followed by selection of stably
transfected cells using G4l8 at a concentration of 800 jig/mI,
which was lethal for primary cells. On day 17, twelve clones were
picked. The morphology of the stably transfected cells was
regularly examined by phase contrast microscopy and docu-
mented after 10 and 52 doublings.
For immunofluorescence, cells were grown in chamber slides
(Lab-Tek, Naperville, IL, USA) until approximately 75% conflu-
ence was reached, fixed in 1:1 (vol:vol) methanol/acetone, washed
with PBS and TWEEN, and then incubated with the respective
antibodies. After 60 minutes unbound antibodies were washed off
and the cells were incubated for another 60 minutes with 50 jil of
an anti-rabbit TRITC conjugated secondary antibody (SV4O T
antigen and VWF) or anti-mouse FITC conjugated secondary
antibody (both diluted 1:40 in PBS) [I. immunofluorescence
micrographs were obtained using a microscope (Lcica DMRBE,
Germany) equipped for photography (Leica DMRD) with Kodak
films. For electron microscopy cells were grown on coverslips
(LabTec) until confluent and fixed with 2% glutaraldehyde for 60
minutes. Further processing including embedding and staining
with 1% tannic acid was performed as described [101.
For the isolation of genomic DNA, confluent cells (clones 2, 3,
4 and 9) were lysed with EDTA/SDS and incubated with RNAse
A at 37°C for one hour. The DNA was purified by phenol/
chloroform extraction, precipitated with ethanol and redissolved
in TE buffer. For Southern blots, genomic MsC DNA was
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Fig. 1. Phase contrast micro graphs of transfected MsC. Using a
magnification of 125 x/250 x, transfected cells are shown before (A)
and after reaching confluency after 4 passages (B) as well as at
confluency after 15 passages (C).
digested to completion with EcoRI, separated on a 0.8% agarose
gel, blotted onto a nylon membrane (GeneScreen; NEN, Boston,
MA, USA) and hybridized with a radioactively labeled SV4O T
antigen probe using standard hybridization conditions [11]. Plas-
mid dilutions representing 1, 3, 5 and 10 copies of the SV4O T
antigen were loaded onto the same gel to serve as the standard.
The number of integrated 5V40 T antigen copies in MsC was
estimated by comparing the signal intensities on the autoradio-
graph with the standards.
For determination of t-PA and PAT-I, primary and transfected
cells were grown to confluency in six-well plates and then stimu-
lated in serum free medium with recombinant human TNF-a
(Boehringer Mannheim) at concentrations of 10, 100, 500 and
1000 U/mI. Stimulation with lipopolysacharide (LPS; Sigma) and
human interleukin In (IL-I; Boehringer Mannheim) was also
performed. The concentrations of t-PA and PAl in the superna-
tant of stimulated and unstimulated cells were determined by
ELISA (Coaliza, Chromogenix). For determination of IL-6 re-
lease confluent transfected MsC were stimulated with recombi-
nant human TNF-a at concentrations of 100 U/mI, 1000 U/mI and
control, and IL-6 concentration in the supernatant was deter-
mined by ELISA.
The concentrations of SpA in the supernatant as well as a
suspension of homogenized cells was measured with ELISA (Byk
Goulden, Konstanz, Germany). Intravital fluorescence micros-
copy (Leica DMRBE) after exposure to phosphin3R for two
minutes at room temperature was performed on transfected cells
and primary MsC. To determine the phospholipid composition of
I( 3
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Fig. 2. Electron micrograph of transfected MsC. (A) Note the presence
of microvilli on the cell surface and tight junctions between individual
cells (arrow). (B) At higher magnification (X11,000) intracellular
granula with lamellar appearance can be observed (arrow) (Micrographs
are a courtesy of P. Mundel and W. Kriz, University of Heidelberg;
used with permission).
the supernatant, cells were washed with PBS twice, incubated for
72hours with serum-free DMEM dexamethasone (Sigma) I 1kM
and the supernatant analyzed by standard thin layer chromatog-
raphy [121.
Expression of WTI was shown using immunofluorescent stain-
ing with a commercially available antibody (C19; Santa Cruz
Biotechnology, Heidelberg, Germany) as described above.
Results and Discussion
Nine of the twelve clones could be continuously passaged and
showed a pattern of slow growth after three to five passages, with
an increase in generation time between the doublings. This
phenomenon has previously been described as "crisis," implicat-
ing the death of non-immortalized cells with a transient prolon-
gation of their life span. Only clones 4 and 9 could be maintained
past the fifth passage post-transfection (approximately 20 dou-
blings), but showed also a sigmoidal growth curve suggestive of a
temporarily limited ability to proliferate. Thereafter, stable
growth with a generation time of approximately three days per
doubling was noted. Re-exposure to 800 g/ml G418 after 34
doublings did not affect cell growth, proving the persistent inte-
gration of the neomycin resistance gene. All subsequent studies
were conducted on clones 4 and 9.
The transfected cells require at least 2.5% serum in the medium
without additional growth factors or coating of culture dishes. The
cells were determined to be free of HIV, hepatitis C, hepatitis B
and mycoplasma. Karyotype analysis showed a human hypodip-
bid karyotype. On Southern blot analysis of various clones a
consistently low number (— 3) of integrated copies of SV4O T
antigen per cell was detected.
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Fig. 3. Indirect immunofluorescent staining of transfected MsC using antibodies against SV4O Tantigen (A), cytoceralin 8/18 (B), cytokeratin 18 (C), and vimentin (D).
The transfected cells showed no apparent differences relative to
primary MsC in morphology during growth, and displayed the
typical cobblestone pattern after reaching confluency (Fig. 1).
Figure 2 shows electron micrographs of transfected cells after 6
passages, that is, 24 doublings. Typical for MsC, the monolayer
shows tight junctions and polarization with microvilli on the
surface [13]. The cytoplasm contains mitochondria, rough endo-
plasmic reticulum, lipid inclusion bodies and parallel electron
dense and electron lucent bands arranged as concentric spheres,
highly suggestive of lamellar bodies. All these features are seen in
primary mesothelial cells [13]. To further evaluate a mesothelial
phenotype immunofluorescent staining was performed (Fig. 3). A
comparison and data from the literature are given in Table 1. The
presence of cytokeratins 8 and 18 as well as vimentin is a generally
Table 1. Comparison of indirect immunofluorescent staining of primary






Vimentin positive positive [4]
Cytokeratin 8/18 positive positive 151
Cytokeratin 18 positive positive [4]
CD 44 positive positive [15]
SV4O T antigen negative positive
PAL-E negative negative [5]
EN 4 negative negative [5]
von Willebrand negative negative [6]
control negative negative
After methanol/acetone fixation, primary and transfected cells were
stained with the respective antibodies as described in the Methods section.
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2000 Fig. 4. (A) Generation of tissue plasminogen
activator (t-PA) and (B) plasminogen activator
= inhibitor (PA 1-1) by prima,y (LI) and
000 transfected mesothelial cells ). MsC wereincubated in serum free medium with
lipopolysaccharide (LPS), interleukin in and
various concentrations of tumor necrosis0 factor a (TNF) and aliquots analyzed by
Control TNF TNF TNF IL-i LPS ELISA. Results are expressed as mean SEM
lOU/mI 100U/ml 1000U/mi lOU/mi long/mi of 3 sets of experiments.
accepted feature of mesothelial cells [4, 5, 9, 14]. The absence of 900
endothelial markers strongly argues against endothelial contami- 800
nation (negative results are not shown). The presence of the SV40 700
T antigen after 55 doublings, along with the persistent G418 600
resistance, demonstrates that these cells are stably transfected [7]. .
Expression of t-PA and PA! has been studied in primary MsC 500[16, 171. Figure 4 shows the amount of t-PA and PA! in the . 400
supernatant of primary and immortalized MsC. A suppression of 300
t-PA concentrations in the supernatant after TNF-n stimulation is 200
observed for both primary and transfected cells. A similar but less —
prominent effect occurs after stimulation with LPS or IL-i (Fig. 100
4A). In contrast, PAl-i release into the supernatant can be 0
induced with TNF-a, LPS or IL-I in primary as well as transfected Control 100 U/mI 1 000 U/mI
MsC (Fig. 4B) [16, 17]. These stimuli also cause a dose dependent Fig. 5. Generation of interleukin 6. Following incubation of transfected
release of IL-6 into the supernatant (Fig. 5) compared with MsC with TNF-a the IL-6 content of the supernatant was determined by
control, which has also been described in primary MsC [18]. ELISA. Results are expressed as mean SEM of 3 sets of experiments.
The generation and reuptake of surfactant-like substances were
other hallmarks of MsC [13, 19, 20]. In pneumocytes II, fluorescence microscopy of MsC shows a marked uptake of
phosphin3R is actively transported into the cytoplasm and stored phosphin3R (Fig. 6A) for primary and transfected cells. The cell
in lamellar granula in the same manner as SpA [21]. Intravital culture supernatant contained 2.0 ngIlOO tl of SpA on ELISA.
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Kephalin
Fig. 7. Expression of W7'J by MsC: Immunohistochemical staining of
transfected MsC using an antibody against W7'I diluted 1:50.
fected MsC a characteristic nuclear pattern can be observed (Fig.





Fig. 6. Surfàctant generation by MsC. (A) Intravital immunofluorescence
of transfected MsC with phosphin3R, indicative of surfactant protein A
reuptake, demonstrates characteristic green fluorescence (arrow). (B)
Thin layer chromatography of the culture medium [in regular DMEM (C)
and with the addition of dexamethasone (D)] of transfected MsC shows
characteristic bands for phosphatidylcholine, sphingomyelin and kephalin.
The homogenate of MsC showed an intracellular SpA concentra-
tion of 57.5 ngIlOO jil, similar to that of rat type II pneumocytes
[22]. These results demonstrate the presence of surfactarit-like
material that is also supported by the presence of lamellar bodies
on electron microscopy and the results of the phospholipid
differentiation (see below). These data are in complete agreement
with the presently scant knowledge about production of surfactant
like material by primary MsC [13]. The secretion of phosphati-
dyicholine and sphingomyelin by primary MsC has been shown
previously [19, 20]. On thin layer chromatography we were able to
show the same components in the supernatant of the transfected
MsC line, as further evidence for surfactant production (Fig. 6).
A highly specific marker of mesothelial cells in adults is Wilms
tumor gene WTI [231. On immunofluorescent staining of trans-
In conclusion, we have established and broadly characterized a
permanent human peritoneal mesothelial cell line that retains the
characteristic features of primary MsC. This MsC line will now
enable us to perform detailed studies of peritoneal MsC biology in
general and of specific influences of various dialysate components.
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